BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:07 PM
 | 
Jul 09, 2010
 |  BC Extra  |  Top Story

Briefing docs highlight FDA Avandia rifts

FDA briefing documents released ahead of a July 13-14 advisory committee meeting on Avandia rosiglitazone from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) reveal divided opinions within the agency's Office of New Drugs (OND) about a key study on the diabetes drug's safety. FDA's Office of Surveillance and Epidemiology (OSE) reiterated its calls for withdrawal of Avandia. FDA...

Read the full 268 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >